Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. SITC is a 501(c)(3) not-for-profit medical professional society of more than 4,650 influential research scientists, physician scientists, clinicians and more dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.
The Society for Immunotherapy of Cancer (SITC) is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 3,000 members who represent over 35 medical specialties in 48 countries.